Forecast to Publish a Notice of Funding Opportunity (NOFO) for NCI Community Oncology Research Program (NCORP) Academic Community Sites (UG1 Clinical Trials Not Allowed)
🏛 National Institutes of Health (HHS-NIH11)
✓ Free, no account · Source: Grants.gov · Last verified Jul 16, 2026
Can you apply?
This grant is for consortia of community hospitals, oncology practices, public hospitals, and academic medical centers seeking to enhance cancer research diversity. Applicants must include a strong academic medical center partner with robust infrastructure. Community-based organizations and academic institutions that serve diverse patient populations are encouraged to apply.
The academic medical center must demonstrate capacity to support patient accrual across multiple affiliate organizations. Consortia must commit to recruiting at least 70 new unique patient participants annually. These participants should be evenly split between cancer control/prevention/screening trials and treatment/imaging trials.
Participants must engage with NCORP Research Bases on protocol development and disparity identification. Participation in cancer care delivery studies is optional but carries specific requirements if included.
Not the right fit? Find grants for your organization in 5 questions →
Key dates
- May 28, 2025 Applications open
- Nov 14, 2025 Application deadline
- Aug 1, 2026 Award announced
- Aug 1, 2026 Project start
Program description
This Notice of Funding Opportunity (NOFO) is one of three NOFOs for the National Cancer Institute (NCI) Community Oncology Research Program (NCORP). NCORP is designed to enhance generalizability and dissemination of clinical trial results through accrual in a variety of community settings. The purpose of NCORP is to engage cancer patient populations, those at risk of cancer, and organizations in rigorous studies focused on cancer control, prevention, treatment and care delivery.
NCORP will support the following components that will be individually awarded through the respective Request for Applications (RFAs) indicated below:
- NCORP Research Bases (UG1 Clinical Trials Required);
- NCORP Community Sites (UG1 Clinical Trials Not Allowed); and
- NCORP Academic Community Sites (UG1 Clinical Trials Not Allowed)
NCORP Academic Community Sites are consortia of community hospitals and/or oncology practices, a public hospital, and an academic medical center that serves a patient population that can enhance the representativeness of participants accrued to cancer control, prevention, treatment and care delivery clinical trials and other human subjects research. The academic medical center should have robust infrastructure to support accrual of participants across their affiliate organizations.
NCORP Academic Community Sites are expected to meet or exceed the required annual 70 new unique patient/participant accruals evenly distributed between cancer control, prevention, and screening/post-treatment surveillance trials, and treatment and imaging trials, respectively. Participation in cancer care delivery studies will be optional. For those who propose cancer care delivery participation, NCORP Academic Community Sites must meet or exceed the required minimum of 3 cancer care delivery protocols open per year. NCORP Academic Community Sites interact with the NCORP Research Bases by: 1) providing insight into clinical significance during concept development; 2) identifying care disparities in their local populations that could be studied; and 3) providing input on feasibility during protocol development.
Who can apply
Eligible applicants
- 501(c)(3) Public Charity
- City / Municipal Government
- Community Health Center
- County Government
- Hospital
- Nonprofits
- Private University
- Public Authority
- Public K-12 School
- Public University
- Small Business (SBA-defined)
- Special District
- State Government
- Tribal Nation
- Tribal Organization
Demographic focus
How to apply
Application links
Key dates & requirements
Required documents
- SF-424 (Federal grant application form)
- Project Narrative/Research Plan
- Budget and Budget Justification
- Biographical Sketches (key personnel)
- Letters of Support (partner institutions)
- Organizational Capacity Documentation
- Diversity Plan
Program contact
- 👤 Brandy Heckman-Stoddard, Ph.D., M.P.H. National Cancer Institute (NCI)
- 📧 heckmanbm@mail.nih.gov
- 📞 240-276-7048
Funding track record
Recent awards under CFDA 93.399 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$22,629,848
-
$20,187,190
-
$19,625,661
-
$19,227,026
-
$18,138,327
-
$17,827,646
-
$17,614,587
-
$16,535,118
-
$16,126,587
-
$14,347,054
Top States by Funding
- NY 7 awards $57.6M
- SC 3 awards $46.6M
- DE 3 awards $43.2M
- IL 3 awards $38.4M
- WI 3 awards $37.9M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
FAQ
Who is eligible to apply?
Consortia with community hospitals, oncology practices, public hospitals, and an academic medical center. The academic center must have strong infrastructure for multi-site patient accrual.
What is the minimum patient accrual requirement?
At least 70 new unique patient participants annually, split evenly between cancer control/prevention/screening and treatment/imaging trials.
Can we include cancer care delivery studies?
Yes, participation is optional. If included, you must maintain 3+ cancer care delivery protocols open per year.
What is the relationship with NCORP Research Bases?
Your consortium provides input during concept development, identifies local care disparities for study, and offers feasibility feedback during protocol development.
When is the deadline?
The Notice of Funding Opportunity will be released with a fixed deadline of November 14, 2025.
💡 Tips for applicants
- Emphasize the academic medical center's infrastructure and experience managing multi-site patient recruitment across affiliates.
- Demonstrate commitment to recruiting diverse patient populations that enhance representativeness in cancer trials.
- Clearly document how your consortium will consistently meet the 70-patient annual accrual target with balanced distribution across trial types.
- Explain your consortium's relationships with NCORP Research Bases and capacity for collaborative protocol development.
- Detail local cancer care disparities your team has identified and how your research addresses them.
⚠️ Common mistakes
Underestimating accrual capacity or proposing unrealistic patient recruitment targets. Failing to demonstrate the academic medical center's robust infrastructure and multi-site management experience. Unclear governance or collaboration structure within the consortium.
Similar grants
- CLOSED Forecast to Publish a Notice of Funding Opportunity (NOFO) for NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Not Allowed) — National Institutes of Health
- CLOSED Forecast to Publish a Notice of Funding Opportunity (NOFO) for NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required) — National Institutes of Health
- OPEN Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) — National Institutes of Health
- OPEN Genomic Community Resources (U24 Clinical Trials Not Allowed) — National Institutes of Health
- OPEN Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) — National Institutes of Health